zaleplon

Generic: zaleplon

Labeler: rising pharma holdings, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name zaleplon
Generic Name zaleplon
Labeler rising pharma holdings, inc.
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

zaleplon 10 mg/1

Manufacturer
Rising Pharma Holdings, Inc.

Identifiers & Regulatory

Product NDC 57237-240
Product ID 57237-240_344d16be-8384-4299-995d-97b48d5d62c0
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA078829
DEA Schedule civ
Listing Expiration 2026-12-31
Marketing Start 2008-06-06

Pharmacologic Class

Established (EPC)
gamma-aminobutyric acid a receptor agonist [epc]
Mechanism of Action
gaba a agonists [moa]
Physiologic Effect
central nervous system depression [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 57237240
Hyphenated Format 57237-240

Supplemental Identifiers

RxCUI
313761 313762
UPC
0357237240014
UNII
S62U433RMH
NUI
N0000183360 N0000000196 N0000175728

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name zaleplon (source: ndc)
Generic Name zaleplon (source: ndc)
Application Number ANDA078829 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 10 mg/1
source: ndc
Packaging
  • 100 CAPSULE in 1 BOTTLE (57237-240-01)
source: ndc

Packages (1)

57237-240-01 100 CAPSULE in 1 BOTTLE (57237-240-01)

Ingredients (1)

zaleplon (10 mg/1)

Linked Drug Pages (1)

ZALEPLON ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "344d16be-8384-4299-995d-97b48d5d62c0", "openfda": {"nui": ["N0000183360", "N0000000196", "N0000175728"], "upc": ["0357237240014"], "unii": ["S62U433RMH"], "rxcui": ["313761", "313762"], "spl_set_id": ["cff46def-c452-49bb-abea-480de8f432bd"], "pharm_class_pe": ["Central Nervous System Depression [PE]"], "pharm_class_epc": ["gamma-Aminobutyric Acid A Receptor Agonist [EPC]"], "pharm_class_moa": ["GABA A Agonists [MoA]"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (57237-240-01)", "package_ndc": "57237-240-01", "marketing_start_date": "20080606"}], "brand_name": "ZALEPLON", "product_id": "57237-240_344d16be-8384-4299-995d-97b48d5d62c0", "dosage_form": "CAPSULE", "pharm_class": ["Central Nervous System Depression [PE]", "GABA A Agonists [MoA]", "gamma-Aminobutyric Acid A Receptor Agonist [EPC]"], "product_ndc": "57237-240", "dea_schedule": "CIV", "generic_name": "ZALEPLON", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ZALEPLON", "active_ingredients": [{"name": "ZALEPLON", "strength": "10 mg/1"}], "application_number": "ANDA078829", "marketing_category": "ANDA", "marketing_start_date": "20080606", "listing_expiration_date": "20261231"}